Organization
Epidemiology and Biostatistics
6 abstracts
Abstract
Pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib (ribo) in Black patients with metastatic breast cancer (mBC): The LEANORA study.Org: Georgetown University Medical Center, Washington, DC, Tufts Medical Center/Tufts University, Boston, MA, National Cancer Institute/National Institutes of Health,
Abstract
Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells.Org: Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Center for Cellular Immunotherapies, Department of Biostatistics, Epidemiology, and Informatics,
Abstract
Analysis of systemic immune changes in patients with advanced cancer treated with immunotoxin LMB-100 and tofacitinib.Org: National Cancer Insititute, Developmental Therapeutics Branch, Nihon Medi-Physics, Epidemiology and Biostatistics, Thoracic and GI Malignancies Branch,
Abstract
‘SCIENTIFIC DATA VISUALIZATION: FOCUS ON (POSTER) PRESENTATIONOrg: Amsterdam University Medical Centers, Vrije Universiteit Brussel, Epidemiology and Biostatistics, Amsterdam Rheumatology and immunology Center,
Abstract
ANTI-CITRULLINE ANTIBODY ASSAY IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITISOrg: Pediatrics, CHU, Kremlin-Bicetre, Leiden University Medical Center, Leiden University, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, VU Medical Center,
Abstract
A double blind, randomized trial of the gastrointestinal safety and efficacy of pentahydrate calcique indometacin compared with diclofenac in patients with osteoarthritis of the kneeOrg: Rheumatology, Epidemiology and Biostatistics, El Ayachi hospital, Salé, university military hospital,